Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HIIP versus injectable insulin in adults with diabetes and COPD or asthma
2005-001527-11Phase 2Terminated
- Sponsor
- Eli Lilly and Company
- Start
- Jun 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label trial of insulin human and human insulin in diabetes mellitus type 1 (T1D) and type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Eli Lilly and Company. Primary endpoints: Change in hemoglobin A1c from baseline to endpoint and Safety assessment. Started Jun 2005; status: terminated.
02
Drugs
insulin humanhuman insulin
03
Conditions
diabetes mellitus type 1 (T1D)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2005-001527-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001527-11.